✉news WorldEU Politics first seen 6 h ago, last 2 h ago, peak #12
EU pharma law package puts pharmacy compounding in focus
Original: Pharmacy compounding under the EU pharma law package – What marketing authorisation holders and innovators need to know
Legal analysis is examining how the EU's pharmaceutical legislation reform package treats pharmacy compounding, and what that means for marketing authorisation holders and innovator companies. The guidance highlights how changes to the rules could affect exemptions for compounded medicines, competition from pharmacies, and how manufacturers protect their products' position in the EU market.
Why now: The EU's reform of pharmaceutical legislation is prompting companies and lawyers to assess how new compounding rules will affect their market exclusivity and obligations.
Rank over time, top of the chart is #1. 4 snapshots from 6 h ago to 2 h ago.
Evidence
- Pharmacy compounding under the EU pharma law package – What marketing authorisation holders and innovators need to know · www.hlc.com
API: https://socialmediatrends-api.osmike.com/v1/trends/518224